跳至主要内容
临床试验/CTRI/2010/091/001268
CTRI/2010/091/001268已完成3 期

A comparative, randomized, single blind, parallel group, and non-crossover, multicentric, clinical study of Vardenafil Tablets Vs Tadalafil Tablets in Men with Erectile Dysfunction.

Ajanta Pharma Ltd0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Availability of subjects for the entire study period and willingness to adhere to protocol requirements as evidenced by written informed consent.
  • 2.Patient with history, signs & symptoms of Erectile Dysfunction (Inability to attain an erection, Inability to sustain an erection, Painful erection, penile pain)

排除标准

  • 1.Male < 18 years of age
  • 3.History of hypersensitivity to the study drug or related products.
  • 4.Significant history or presence of gastrointestinal, liver or kidney disease, or any other conditions known to interfere with the absorption, distribution, metabolism or excretion of common medications.
  • 5.Patients with hypogonadism or anatomical deformities such as severe penile fibrosis.
  • 6.Any clinical significant illness during the 4 weeks prior to day 1 of this study.
  • 7.Participation in a clinical trial with an investigation drug within 30 days proceeding day 1 of this study.
  • 8.Any condition that, in the opinion of the investigator, does not justify the patient?s inclusion in the study.

研究者

相似试验